Compounding for autoimmune diseases and inflammation
Auto-Immune conditions affect up to 10-20% of the U.S. population. Auto-Immune disorders are a result of the immune system attacking organs or tissues causing inflammation and various symptoms depending on where the attack is.
Unfortunately, if you have one auto-immune disorder, your risk for another auto-immune condition is increased.
Our expert pharmacists work with medical specialists to develop a customized plan of action to provide relief.
Common autoimmune conditions
- Celiac disease
- Rheumatoid arthritis
- Multiple sclerosis
- Type 1 diabetes
- Crohn’s Disease
- Inflammatory bowel disease
- Hashimoto’s Disease
Low Dose Naltrexone (LDN) for autoimmune conditions
Low dose naltrexone (LDN) has been studied for decades for its utilization in reducing inflammation, specifically for those living with chronic pain and autoimmune conditions.
While Naltrexone was primarily utilized for for opioid addiction, a doctor in New York, Dr. Bernard Bihari, discovered that when it was taken at a much lower dose, LDN exhibited beneficial results for patients with autoimmunity, cancer, and HIV or AIDS. This is why the name Low dose Naltrexone (LDN) has been established.
Autoimmune patients typically have lower levels of endorphins than people without autoimmunity. In many patients that are on LDN therapy, endorphin levels are increased and symptoms are decreased. Practitioners have been prescribing LDN to more patients that have had difficulty with commercially available options.
"LDN may become a promising immunomodulatory agent in the therapy for cancer and many immune-related diseases. "
Source: International Immunopharmacology
LDN must be made through a compounding pharmacy and requires a prescription.
It can be created in many forms depending on the symptoms a patients is experiencing.
Here to help.
Optimize your patients’ experiences with addressing symptoms of autoimmune disease by providing medications that cater to their comfort and specific needs.